Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03120702 · ClinicalTrials.gov registry record · NA
Measurement of Total Hemoglobin by Pulse Oximetry in Neonatal Population
A NA study of Anemia, sponsored by Masimo Corporation.
- Completed
- Registry status
- NA
- Development phase
- 128
- Enrollment target
- 1
- Study location
NCT03120702: Completed NA study of Anemia, sponsored by Masimo Corporation.
NCT03120702 is a NA study of Anemia that has completed, run by Masimo Corporation. The registered enrollment target is 128 participants, below the 426-participant average among 72 other Anemia trials with a reported enrollment target (70% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03120702, a NA study of Anemia, has completed, sponsored by Masimo Corporation.
- COMPLETED
- Registry status
- NA
- Development phase
- 128 participants
- Enrollment target
- 1
- Study location
Study Summary
Assess ability of Masimo SpHb sensor to demonstrate robust performance on various sensor application sites on neonates/infants
Primary Outcome
To study the SpHb sensor in neonatal population.
Conditions Studied
Interventions
- DEVICE Investigational Rainbow SpHb sensor
Study Locations (1)
California
- Children's Hospital of Orange County - Orange
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 128 participants |
| Start Date | 2013-07-23 |
| Est. Completion | 2017-04-20 |
| Phase | NA |
What the finished NCT03120702 record still lists
NCT03120702 is an interventional study that assigns participants to a tested intervention. The registered 128 participants enrollment target is mid-sized for trials with a published cap, below the 426-participant average among 72 other Anemia trials with a reported enrollment target (70% lower).
The record links to 1 condition, with Anemia appearing as the primary indexed condition, and to 1 intervention - of which Investigational Rainbow SpHb sensor is the first listed.
NCT03120702 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT03120702 about?
NCT03120702 is a clinical study titled "Measurement of Total Hemoglobin by Pulse Oximetry in Neonatal Population". Assess ability of Masimo SpHb sensor to demonstrate robust performance on various sensor application sites on neonates/infants
What is the current status of trial NCT03120702?
This trial is currently completed. It is a NA study. The enrollment target is 128 participants. The study started on 2013-07-23. Estimated completion is 2017-04-20.
What conditions does trial NCT03120702 study?
This clinical trial studies the following conditions: Anemia.
What interventions are being tested in trial NCT03120702?
The interventions under investigation include: Investigational Rainbow SpHb sensor (DEVICE).
Who is sponsoring clinical trial NCT03120702?
This trial is sponsored by Masimo Corporation, which has 96 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03120702 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Anemia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03120702's enrollment target sits among peer trials
128 41st of 72 higher than 32 of 72 other Anemia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Anemia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Kids With Iron Deficiency and Scoliosis
RECRUITING · NA
-
Effectiveness of Small Phlebotomy Tubes in Reducing Blood Transfusions in Adult Medical Intensive Care Unit and Intermediate Care Unit Patients With Anemia
RECRUITING · NA
-
A New Combination of Evidence-Based Interventions to Improve Primary Care Diagnostic Safety and Efficiency
RECRUITING · NA
-
The Immediate and Long-term Effects of a Novel Marine-based Iron Supplement in Adult Females
ACTIVE NOT RECRUITING · NA
-
Effects of Vitamin D and Marine Omega-3 Fatty Acids on Anemia
ACTIVE NOT RECRUITING · NA
-
Placental Transfusion in Term Infants: A Pilot Study
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02870738 · 128 participants · Phase 2
Bladder Directed vs. Pelvic Floor Therapy in IC/BPS
- NCT03294460 · 128 participants · Phase 1
Nicotinic Receptor Genetic Variation and Alcohol Reward
- NCT04149977 · 128 participants · NA
Blood Flow Restriction Therapy in Lower Limb Extensor Injuries
- NCT04373057 · 128 participants · Phase 1
Prebiotic Galacto-oligosaccharide and Acute GVHD
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI